|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.70 CHF | -0.42% |
|
+4.15% | -10.40% |
| Jul. 07 | Swiss stocks - Factors to watch on July 7 | RE |
| Jul. 06 | Alcon Signs Joint Development, License Deal for Adjustable Lenses with RxSight | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.03 | 1.79 | 2.26 | 2.85 | 2.57 | |||||
Return on Total Capital | 2.39 | 2.11 | 2.62 | 3.26 | 2.95 | |||||
Return On Equity % | 1.97 | 1.72 | 4.83 | 4.83 | 4.5 | |||||
Return on Common Equity | 1.97 | 1.72 | 4.83 | 4.83 | 4.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.64 | 55.15 | 55.49 | 55.65 | 55.67 | |||||
SG&A Margin | 36.87 | 35.2 | 33.94 | 32.79 | 33.16 | |||||
EBITDA Margin % | 24.57 | 21.44 | 23.15 | 25.23 | 22.41 | |||||
EBITA Margin % | 20.7 | 17.61 | 19.1 | 21.3 | 19.79 | |||||
EBIT Margin % | 10.87 | 9.41 | 11.22 | 13.8 | 12.25 | |||||
Income From Continuing Operations Margin % | 4.54 | 3.84 | 10.3 | 10.27 | 9.42 | |||||
Net Income Margin % | 4.54 | 3.84 | 10.3 | 10.27 | 9.42 | |||||
Net Avail. For Common Margin % | 4.54 | 3.84 | 10.3 | 10.27 | 9.42 | |||||
Normalized Net Income Margin | 5.62 | 4.53 | 5.73 | 7.63 | 6.47 | |||||
Levered Free Cash Flow Margin | 6.73 | 4.4 | 4.66 | 13.62 | 11.86 | |||||
Unlevered Free Cash Flow Margin | 7.64 | 5.36 | 5.91 | 14.83 | 13.09 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.3 | 0.3 | 0.32 | 0.33 | 0.34 | |||||
Fixed Assets Turnover | 2.11 | 2.05 | 2.07 | 2.07 | 2.07 | |||||
Receivables Turnover (Average Receivables) | 5.37 | 5.14 | 5.12 | 5.26 | 5.25 | |||||
Inventory Turnover (Average Inventory) | 2.03 | 1.95 | 1.9 | 1.92 | 1.98 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.18 | 1.87 | 2.28 | 2.77 | 2.12 | |||||
Quick Ratio | 1.36 | 1.06 | 1.28 | 1.71 | 1.28 | |||||
Operating Cash Flow to Current Liabilities | 0.54 | 0.44 | 0.56 | 0.91 | 0.74 | |||||
Days Sales Outstanding (Average Receivables) | 67.94 | 71.03 | 71.31 | 69.56 | 69.54 | |||||
Days Outstanding Inventory (Average Inventory) | 179.86 | 187.07 | 192.17 | 191.08 | 184.4 | |||||
Average Days Payable Outstanding | 84.33 | 78.14 | 69.02 | 66.76 | 65.5 | |||||
Cash Conversion Cycle (Average Days) | 163.47 | 179.96 | 194.46 | 193.88 | 188.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.3 | 25.81 | 24.95 | 23.85 | 23.81 | |||||
Total Debt / Total Capital | 18.89 | 20.51 | 19.97 | 19.26 | 19.23 | |||||
LT Debt/Equity | 22.36 | 24.9 | 23.9 | 23.05 | 20.84 | |||||
Long-Term Debt / Total Capital | 18.13 | 19.79 | 19.13 | 18.61 | 16.83 | |||||
Total Liabilities / Total Assets | 31.23 | 32.63 | 30.36 | 28.98 | 30.17 | |||||
EBIT / Interest Expense | 7.51 | 6.12 | 5.61 | 7.12 | 6.25 | |||||
EBITDA / Interest Expense | 17.65 | 14.51 | 12.06 | 13.46 | 11.86 | |||||
(EBITDA - Capex) / Interest Expense | 11.82 | 6.15 | 8.57 | 10.99 | 9.2 | |||||
Total Debt / EBITDA | 2.12 | 2.61 | 2.26 | 1.99 | 2.17 | |||||
Net Debt / EBITDA | 1.37 | 2.11 | 1.77 | 1.28 | 1.5 | |||||
Total Debt / (EBITDA - Capex) | 3.16 | 6.16 | 3.18 | 2.43 | 2.79 | |||||
Net Debt / (EBITDA - Capex) | 2.05 | 4.97 | 2.5 | 1.56 | 1.94 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 21.34 | 5.14 | 8.47 | 4.82 | 4.94 | |||||
Gross Profit, 1 Yr. Growth % | 53.66 | 2.36 | 9.15 | 4.97 | 4.99 | |||||
EBITDA, 1 Yr. Growth % | 60.39 | -3.31 | 12.84 | 13.01 | -6.8 | |||||
EBITA, 1 Yr. Growth % | 75.28 | -4.78 | 12.45 | 15.36 | -2.51 | |||||
EBIT, 1 Yr. Growth % | -438.72 | 2.89 | 19.08 | 26.08 | -6.87 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -170.81 | -10.9 | 190.75 | 4.52 | -3.73 | |||||
Net Income, 1 Yr. Growth % | -170.81 | -10.9 | 190.75 | 4.52 | -3.73 | |||||
Normalized Net Income, 1 Yr. Growth % | -279.52 | -1.4 | 23.33 | 35.8 | -11.07 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -169.72 | -10.53 | 188.24 | 4.59 | -3.41 | |||||
Accounts Receivable, 1 Yr. Growth % | 8.51 | 11.42 | 6.25 | -1.75 | 12.2 | |||||
Inventory, 1 Yr. Growth % | 15.51 | 11.06 | 10.1 | -2.33 | 5.42 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.93 | 8.16 | 6.95 | 2.43 | 7.92 | |||||
Total Assets, 1 Yr. Growth % | 1.45 | 4.32 | 1.54 | 2.48 | 3.98 | |||||
Tangible Book Value, 1 Yr. Growth % | 38.53 | -35.81 | 148.4 | 52.39 | -6.17 | |||||
Common Equity, 1 Yr. Growth % | 2.31 | 2.19 | 4.81 | 4.5 | 2.23 | |||||
Cash From Operations, 1 Yr. Growth % | 63.43 | -9.52 | 14.05 | 49.64 | 9.34 | |||||
Capital Expenditures, 1 Yr. Growth % | 46.14 | 60.14 | -41.12 | -28.33 | 14.8 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -39.42 | -22.18 | 14.81 | 206.12 | -8.61 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -36.61 | -17.71 | 19.5 | 162.91 | -7.4 | |||||
Dividend Per Share, 1 Yr. Growth % | 94.11 | 3.52 | 25.5 | 8.41 | 14.28 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.09 | 12.95 | 6.79 | 6.63 | 4.88 | |||||
Gross Profit, 2 Yr. CAGR % | 13.33 | 25.36 | 5.7 | 7.09 | 5.05 | |||||
EBITDA, 2 Yr. CAGR % | 18.69 | 35.17 | 5.84 | 14.7 | 2.79 | |||||
EBITA, 2 Yr. CAGR % | 20.64 | 45.41 | 5.16 | 15.99 | 6.25 | |||||
EBIT, 2 Yr. CAGR % | 207.96 | 25.7 | 13.89 | 22.21 | 8.71 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -24.29 | -20.57 | 60.95 | 74.32 | 0.31 | |||||
Net Income, 2 Yr. CAGR % | -24.29 | -20.57 | 60.95 | 74.32 | 0.31 | |||||
Normalized Net Income, 2 Yr. CAGR % | 311.48 | -2.73 | 14.44 | 28.92 | 10.33 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -24.79 | -21.02 | 60.59 | 73.63 | 0.51 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.64 | 9.96 | 8.81 | 2.17 | 4.99 | |||||
Inventory, 2 Yr. CAGR % | 12.33 | 13.26 | 10.58 | 3.7 | 1.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.99 | 8.04 | 7.55 | 4.67 | 5.14 | |||||
Total Assets, 2 Yr. CAGR % | 0.62 | 2.87 | 2.84 | 2.01 | 3.23 | |||||
Tangible Book Value, 2 Yr. CAGR % | 55 | -18.88 | 28.97 | 94.56 | 19.58 | |||||
Common Equity, 2 Yr. CAGR % | -0.12 | 2.25 | 3.49 | 4.66 | 3.36 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.91 | 21.6 | 1.59 | 30.64 | 27.91 | |||||
Capital Expenditures, 2 Yr. CAGR % | 12.51 | 52.98 | -2.9 | -35.04 | -9.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -16.62 | -29.36 | -6.67 | 104.2 | 68.1 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -14.86 | -25.69 | -1.92 | 89.93 | 56.65 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 41.75 | 13.98 | 16.64 | 11.31 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.04 | 5.1 | 11.43 | 6.13 | 6.06 | |||||
Gross Profit, 3 Yr. CAGR % | 9.59 | 9.55 | 19.7 | 5.5 | 6.38 | |||||
EBITDA, 3 Yr. CAGR % | 5.01 | 8.93 | 28.86 | 8.58 | 7.03 | |||||
EBITA, 3 Yr. CAGR % | 4.17 | 9.19 | 35.5 | 8.94 | 9.46 | |||||
EBIT, 3 Yr. CAGR % | 95.27 | 105.13 | 26.92 | 18.7 | 11.62 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.32 | -20.07 | 22.41 | 39.38 | 43.02 | |||||
Net Income, 3 Yr. CAGR % | 18.32 | -20.07 | 22.41 | 39.38 | 43.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | 119.96 | 143.08 | 9.08 | 22.27 | 13.91 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.8 | -20.31 | 21.6 | 39.2 | 42.8 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.25 | 5.49 | 8.71 | 5.17 | 5.41 | |||||
Inventory, 3 Yr. CAGR % | 9.66 | 11.9 | 12.2 | 6.1 | 4.27 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.35 | 8.71 | 7.68 | 5.82 | 5.74 | |||||
Total Assets, 3 Yr. CAGR % | 1.14 | 1.84 | 2.38 | 2.72 | 2.66 | |||||
Tangible Book Value, 3 Yr. CAGR % | -13.46 | 4.5 | 19.47 | 36.35 | 52.57 | |||||
Common Equity, 3 Yr. CAGR % | -5.25 | 0.64 | 3.09 | 3.83 | 3.84 | |||||
Cash From Operations, 3 Yr. CAGR % | 5.67 | 9.77 | 19.03 | 15.59 | 23.11 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.13 | 26.56 | 11.28 | -12.25 | -21.46 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -21.77 | -21.81 | -16.92 | 38.67 | 56.2 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -18.76 | -18.81 | -12.92 | 36.24 | 49.49 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 36.11 | 12.09 | 15.85 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.68 | 5.12 | 5.74 | 5.71 | 8.77 | |||||
Gross Profit, 5 Yr. CAGR % | 8.54 | 8.45 | 8.02 | 8.57 | 13.61 | |||||
EBITDA, 5 Yr. CAGR % | 9.11 | 6.6 | 4.47 | 11.58 | 17.91 | |||||
EBITA, 5 Yr. CAGR % | 9.76 | 6.07 | 3.54 | 12.36 | 23.17 | |||||
EBIT, 5 Yr. CAGR % | 74.3 | 72.94 | 54.38 | 70.48 | 19.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 17.21 | 5.53 | 33.82 | 9.19 | 13.04 | |||||
Net Income, 5 Yr. CAGR % | 17.21 | 5.53 | 33.82 | 9.19 | 13.04 | |||||
Normalized Net Income, 5 Yr. CAGR % | 66.63 | 191.55 | 65.42 | 94.03 | 10 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 5.51 | 33.34 | 8.82 | 12.68 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.57 | 3.18 | 6.05 | 4.15 | 7.21 | |||||
Inventory, 5 Yr. CAGR % | 9.49 | 10.11 | 10.03 | 8.55 | 7.78 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.25 | 11.52 | 10.41 | 7.08 | 6.66 | |||||
Total Assets, 5 Yr. CAGR % | 0.19 | 1.3 | 1.82 | 1.88 | 2.71 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.17 | -18.18 | -4.42 | 35.14 | 19.51 | |||||
Common Equity, 5 Yr. CAGR % | -3.5 | -3.1 | -1.85 | 2.23 | 3.2 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.56 | -0.02 | 4.02 | 17.69 | 22.51 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.53 | 21.99 | 4.72 | -3.08 | 2.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.66 | -14.43 | -17.67 | 10.96 | 9.91 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -2.75 | -11.33 | -13.88 | 10.97 | 9.96 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | 25.59 |
- Stock Market
- Stocks
- ALC Stock
- Financials Alcon Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















